ISO 15197:2013
In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus
ISO 15197:2013 specifies requirements for in vitro glucose monitoring systems that measure glucose concentrations in capillary blood samples, for specific design verification procedures and for the validation of performance by the intended users. These systems are intended for self-measurement by lay persons for management of diabetes mellitus.
ISO 15197:2013 is applicable to manufacturers of such systems and those other organizations (e.g. regulatory authorities and conformity assessment bodies) having the responsibility for assessing the performance of these systems.
| Get this standard | Prices exclude GST | |
|---|---|---|
| PDF ( Single user document) |
$248.54 NZD
|
|
| HardCopy |
$248.54 NZD
|
|
| Networkable PDF |
Price varies
|
Keep me up-to-date
Sign up to receive updates when there are changes to this standard
Related Information
Similar Standards
-
BS EN 13532:2002
General requirements for in vitro diagnostic medical devices for self-testing
-
BS EN 13612:2002
Performance evaluation of in vitro diagnostic medical devices
-
BS EN 13641:2002
Elimination or reduction of risk of infection related to in vitro diagnostic reagents
-
BS EN 13975:2003
Sampling procedures used for acceptance testing of in vitro diagnostic medical devices. Statistical aspects